Market Value417,341,689
Total Holdings76
File Date2024-02-14
Original Filing (Click here)

All hedge funds or institutions that manage over $100M are required by the SEC to file quarterly reports on their holdings. These reports are called 13F reports. However, the filings are required the following quarter from the reporting period, which means that by the time the filing is made (and we see them), the information could be five months old.

For funds with long term positions that make few trades, the holdings might closely resemble their current holdings, even after several months. However, for funds that have high turnover, the holdings data we see might differ significantly from their current holdings. Institutions are required to report CALL and PUT options, and those positions are identified in the table. However, they are not required to report short positions.

Click the link icon to see the full transaction history.

Upgrade to unlock premium data and export to Excel .

Security Imputed
Share Price
Prev
Shares
Current
Shares
Change
(Percent)
Prev Value
(USD x1000)
Current Value
(USD x1000)
Change
(Percent)
MREO / Mereo BioPharma Group plc - Depositary Receipt (Common Stock)
KALV / KalVista Pharmaceuticals, Inc.
MRUS / Merus N.V.
ASND / Ascendis Pharma A/S - Depositary Receipt (Common Stock)
STIM / Neuronetics, Inc.
KRTX / Karuna Therapeutics, Inc.
SPRO / Spero Therapeutics, Inc.
MLYS / Mineralys Therapeutics, Inc.
SPRB / Spruce Biosciences, Inc.
INGN / Inogen, Inc.
PRCT / PROCEPT BioRobotics Corporation
RCUS / Arcus Biosciences, Inc.
RGLS / Regulus Therapeutics Inc.
SAGE / Sage Therapeutics, Inc.
IDYA / IDEAYA Biosciences, Inc.
IBB / iShares Trust - iShares Biotechnology ETF
SNDX / Syndax Pharmaceuticals, Inc.
RVMD / Revolution Medicines, Inc.
CYTK / Cytokinetics, Incorporated
KURA / Kura Oncology, Inc.
IMGN / ImmunoGen, Inc.
NXTC / NextCure, Inc.
MRSN / Mersana Therapeutics, Inc.
THRD / Third Harmonic Bio, Inc.
CERE / Cerevel Therapeutics Holdings, Inc.
ATXS / Astria Therapeutics, Inc.
BPMC / Blueprint Medicines Corporation
BHVN / Biohaven Ltd.
STRO / Sutro Biopharma, Inc.
PRQR / ProQR Therapeutics N.V.
XENE / Xenon Pharmaceuticals Inc.
ORIC / ORIC Pharmaceuticals, Inc.
STXS / Stereotaxis, Inc.
VIGL / Vigil Neuroscience, Inc.
ELEV / Elevation Oncology, Inc.
ARGX / argenx SE - Depositary Receipt (Common Stock)
AMLX / Amylyx Pharmaceuticals, Inc.
MGNX / MacroGenics, Inc.
CGEM / Cullinan Therapeutics, Inc.
MRTX / Mirati Therapeutics, Inc.
VTGN / Vistagen Therapeutics, Inc.
ACET / Adicet Bio, Inc.
LRMR / Larimar Therapeutics, Inc.
NRIX / Nurix Therapeutics, Inc.
SLRN / Acelyrin, Inc.
KNTE / Kinnate Biopharma Inc.
SYRS / Syros Pharmaceuticals, Inc.
IPSC / Century Therapeutics, Inc.
ATRC / AtriCure, Inc.
KPTI / Karyopharm Therapeutics Inc.
SPRY / ARS Pharmaceuticals, Inc.
NVRO / Nevro Corp.
NBIX / Neurocrine Biosciences, Inc.
CGEN / Compugen Ltd.
EWTX / Edgewise Therapeutics, Inc.
DXCM / DexCom, Inc.
DAWN / Day One Biopharmaceuticals, Inc.
IMVT / Immunovant, Inc.
TNDM / Tandem Diabetes Care, Inc.
ACRV / Acrivon Therapeutics, Inc.
GOSS / Gossamer Bio, Inc.
BCRX / BioCryst Pharmaceuticals, Inc.
ASND / Ascendis Pharma A/S - Depositary Receipt (Common Stock)
ITOS / iTeos Therapeutics, Inc.
TSVT / 2seventy bio, Inc.
BWAY / BrainsWay Ltd. - Depositary Receipt (Common Stock)
XBI / SPDR Series Trust - SPDR S&P Biotech ETF
ALEC / Alector, Inc.
IMTX / Immatics N.V.
ARAY / Accuray Incorporated
CMPS / COMPASS Pathways plc - Depositary Receipt (Common Stock)
VKTX / Viking Therapeutics, Inc.
GLPG / Galapagos NV - Depositary Receipt (Common Stock)
MDWD / MediWound Ltd.
BCYC / Bicycle Therapeutics plc - Depositary Receipt (Common Stock)
MORF / Morphic Holding, Inc.
MASI / Masimo Corporation
AUTL / Autolus Therapeutics plc - Depositary Receipt (Common Stock)
KROS / Keros Therapeutics, Inc.
ADAP / Adaptimmune Therapeutics plc - Depositary Receipt (Common Stock)
AXGN / Axogen, Inc.
CMPX / Compass Therapeutics, Inc.